AMRI has signed a definitive agreement to acquire all outstanding shares of Cedarburg Pharmaceuticals, Inc., a contract developer and manufacturer of complex API’s, for $38.2 million in cash. The transaction expands AMRI’s position as a s… Read More »
Feel Better Now?
Ending one year, approaching the next
By Michael A. Martorelli
It’s always interesting to write a column about an event that is still in my future, but will have already happened by the time you read my words. Th… Read More »